Deliver Botox® today

Proven Prevention Your Hands

8 to 9 fewer headache days per month from baseline at week 24 (vs 6 to 7 with placebo).1

For adults with Chronic Migraine, 15 or more headache days a month, each lasting 4 hours or more. It is not approved for 14 or fewer headache days a month.

PROVEN: 8 to 9 fewer headache days per month from baseline at week 24 (vs 6 to 7 with placebo).1

PRECISE: PREEMPT* Protocol – the only locally administered procedure delivered with purposeful fixed-site, fixed-dose injections into 7 head and neck muscle areas.1,2

PREDICTABLE: a legacy of ~15 years in Chronic Migraine, and counting.3,†

15-year logo

*PREEMPT = Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy.

Since FDA approval in 2010.3

BOTOX® #1 prescribed branded Chronic Migraine preventive treatment

Identify and treat your appropriate Chronic Migraine patients sooner with BOTOX®

  • SAVINGS: With the BOTOX® Savings Program, eligible, commercially insured patients may pay as little as $0 for treatment.§ Patients may save up to $4000 per year and up to $1300 for the first treatment in each calendar yearǁ
  • SUPPORT: BOTOX TODAY offers comprehensive support. Contact your AbbVie Account Specialist to find out about access and reimbursement support and education

§Available to patients with commercial insurance coverage for BOTOX® who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions visit abbv.ie/bsp-terms or call 1-800-44-BOTOX for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.

ǁBy participating in the BOTOX® Savings Program, you acknowledge and agree to the full Terms and Conditions set out at BOTOXSavingsProgram.com/TermsandConditions. Patients enrolled in Medicare, Medicaid, TRICARE, or any other government-reimbursed healthcare program are not eligible. Other restrictions and maximum limits apply.

According to a survey of patients currently using BOTOX® for Chronic Migraine treatment (n = 78).5

Circle chart showing 92%

In a survey

91%

wish they talked to their doctor and started treatment sooner5,¶

According to a survey of patients currently using BOTOX® for Chronic Migraine treatment (n = 78).5

Circle chart showing 75%

75%

of patients did not receive a Chronic Migraine diagnosis6,#

#In a study of Chronic Migraine patients (n = 512) who had sought evaluation from a healthcare professional (specialist or non-specialist) for their headaches.6

Do you have undiagnosed Chronic Migraine patients in your practice?

#In a study of Chronic Migraine patients (n = 512) who had sought evaluation from a healthcare professional (specialist or non-specialist) for their headaches.6

A doctor holding a clipboard, having a conversation with a patient 

Proven

8 to 9 fewer headache days per month from baseline at week 24 (vs 6 to 7 with placebo).1

Precise

PREEMPT Protocol—the only locally administered procedure delivered with purposeful fixed-site, fixed-dose injections into 7 head and neck muscle areas.1,2

Healthcare professional drawing BOTOX® from a vial into a syringe 
BOTOX® vial and syringe, with doctor blurred in background 

Predictable

A legacy of ~15 years in Chronic Migraine, and counting3,††

††Since FDA approval in October 2010.3

MAXEdGETM

MAXEdge logo

With the MAXEdGE™ Program from AbbVie, you can seek the extra EdGE in support with extensive resources and tailored education

1 Million Chronic Migraine patients treated 
BOTOX® Chronic Migraine samples message 
Next Page
MAXEdge logo 

MAXEdGETM for Advanced Practice Providers (APPs) looking to advance expertise in Chronic Migraine patient care

See what you can discover by joining the MAXEdGE™ program—a community of peers working together to identify and treat Chronic Migraine patients